- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
834
Companies which are more than 50% undervalued based on analyst price target.
834 companies
BioRestorative Therapies
Market Cap: US$13.7m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.80
7D
-2.2%
1Y
31.4%
Harvard Bioscience
Market Cap: US$13.5m
Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.
HBIO
US$0.32
7D
-9.4%
1Y
-91.1%
GeoVax Labs
Market Cap: US$13.4m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
GOVX
US$0.93
7D
-8.2%
1Y
-40.5%
Vivesto
Market Cap: SEK 125.1m
Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.23
7D
1.1%
1Y
-24.3%
IN8bio
Market Cap: US$12.8m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.
INAB
US$0.16
7D
-7.1%
1Y
-84.4%
ProPhase Labs
Market Cap: US$12.7m
Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.
PRPH
US$0.30
7D
-8.4%
1Y
-94.0%
Hoth Therapeutics
Market Cap: US$12.5m
A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.
HOTH
US$0.95
7D
7.1%
1Y
-18.6%
NextCure
Market Cap: US$12.5m
A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
NXTC
US$0.45
7D
0.8%
1Y
-73.0%
Imunon
Market Cap: US$12.1m
A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.
IMNN
US$0.80
7D
-4.4%
1Y
-42.0%
Relmada Therapeutics
Market Cap: US$12.1m
Operates as a clinical-stage biotechnology company in the United States.
RLMD
US$0.42
7D
14.9%
1Y
-88.1%
Bionano Genomics
Market Cap: US$11.6m
Provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
BNGO
US$3.84
7D
-5.3%
1Y
-93.3%
Active Biotech
Market Cap: SEK 111.7m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.091
7D
13.2%
1Y
-82.3%
Affimed
Market Cap: US$11.5m
A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.
AFMD
US$0.69
7D
-28.6%
1Y
-87.0%
Nanologica
Market Cap: SEK 110.9m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
NICA
SEK 1.26
7D
3.7%
1Y
-77.9%
Cellectar Biosciences
Market Cap: US$11.4m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$0.25
7D
-8.6%
1Y
-91.9%
Kairos Pharma
Market Cap: US$11.4m
A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.
KAPA
US$0.68
7D
-16.3%
1Y
n/a
Minerva Neurosciences
Market Cap: US$11.3m
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
NERV
US$1.61
7D
-5.3%
1Y
-32.6%
IXICO
Market Cap: UK£8.3m
Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.
IXI
UK£0.09
7D
0%
1Y
22.0%
Plus Therapeutics
Market Cap: US$10.5m
A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.
PSTV
US$0.66
7D
1.9%
1Y
-69.4%
Athira Pharma
Market Cap: US$10.4m
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
ATHA
US$0.25
7D
-11.7%
1Y
-88.0%
Coegin Pharma
Market Cap: SEK 99.5m
A biotechnology company, engages in the discovery and development of dermacosmetic products and drugs for the treatment of serious diseases associated with diabetes and cancer.
COEGIN
SEK 4.00
7D
2.3%
1Y
19.4%
Biosergen
Market Cap: SEK 98.2m
A biotech company, develops antifungal products.
BIOSGN
SEK 0.42
7D
29.4%
1Y
34.4%
Abpro Holdings
Market Cap: US$9.9m
A biotechnology company, provides antibody therapeutics for cancer related issues.
ABP
US$0.20
7D
-13.0%
1Y
-98.2%
Kiora Pharmaceuticals
Market Cap: US$9.8m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.
KPRX
US$3.25
7D
-2.0%
1Y
-25.7%
Pharma-Bio Serv
Market Cap: US$9.7m
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.50
7D
11.7%
1Y
-33.3%
Cardio Diagnostics Holdings
Market Cap: US$9.7m
Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
CDIO
US$0.19
7D
-56.7%
1Y
-79.6%
Sensei Biotherapeutics
Market Cap: US$9.5m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$0.36
7D
-15.1%
1Y
-76.2%
Talphera
Market Cap: US$9.4m
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
TLPH
US$0.54
7D
0.9%
1Y
-46.8%
Evaxion Biotech
Market Cap: US$9.2m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$1.49
7D
-5.1%
1Y
-92.0%
Aprea Therapeutics
Market Cap: US$9.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.62
7D
-12.4%
1Y
-71.0%
Carisma Therapeutics
Market Cap: US$9.0m
A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.
CARM
US$0.19
7D
-23.7%
1Y
-87.1%
Dogwood Therapeutics
Market Cap: US$8.7m
A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.
DWTX
US$4.56
7D
-9.2%
1Y
-48.6%
Neuphoria Therapeutics
Market Cap: US$8.7m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$5.01
7D
-0.9%
1Y
n/a
BioXcel Therapeutics
Market Cap: US$8.6m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$1.53
7D
-14.0%
1Y
-95.4%
Intensity Therapeutics
Market Cap: US$8.6m
A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.
INTS
US$0.54
7D
-5.9%
1Y
-86.5%
Phio Pharmaceuticals
Market Cap: US$8.6m
A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.
PHIO
US$1.76
7D
-10.2%
1Y
-72.2%